Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,082 | 197 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $467.26 | 36 | $0 (2024) |
| Novo Nordisk Inc | $392.19 | 31 | $0 (2024) |
| Amgen Inc. | $302.65 | 22 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $247.85 | 12 | $0 (2024) |
| Lilly USA, LLC | $245.19 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $239.46 | 15 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $196.14 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $187.72 | 12 | $0 (2024) |
| PFIZER INC. | $130.26 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $96.63 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $826.19 | 43 | ABBVIE INC. ($181.11) |
| 2023 | $560.58 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($71.36) |
| 2022 | $1,006 | 71 | ABBVIE INC. ($188.79) |
| 2021 | $689.32 | 50 | Novo Nordisk Inc ($130.53) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Hematology | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardio-renal | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $45.08 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PAIN | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Gastroenterology | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardio-renal | ||||||
| 08/02/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $39.44 | General |
| Category: Hematology | ||||||
| 07/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Oncology | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 644 | 1,634 | $111,569 | $44,648 |
| 2022 | 10 | 727 | 1,432 | $108,360 | $47,314 |
| 2021 | 14 | 780 | 1,533 | $96,930 | $40,406 |
| 2020 | 11 | 648 | 1,181 | $82,642 | $29,786 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 379 | $66,436 | $28,341 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 211 | $25,410 | $11,207 | 44.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 62 | $4,650 | $2,019 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $3,519 | $1,766 | 50.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 91 | 116 | $5,800 | $898.72 | 15.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $550.00 | $314.60 | 57.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 54 | 736 | $3,680 | $61.46 | 1.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 72 | $1,224 | $27.95 | 2.3% |
| J1940 | Injection, furosemide, up to 20 mg | Office | 2023 | 12 | 30 | $300.00 | $12.76 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 322 | $56,350 | $25,314 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 199 | $20,060 | $10,579 | 52.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 22 | 24 | $7,392 | $3,182 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $6,003 | $3,056 | 50.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 67 | 71 | $4,995 | $2,165 | 43.3% |
| 98967 | Telephone medical discussion provided by nonphysician professional, 11-20 minutes | Office | 2022 | 79 | 91 | $4,732 | $1,523 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 61 | 77 | $3,850 | $630.64 | 16.4% |
| 98966 | Telephone medical discussion provided by nonphysician professional, 5-10 minutes | Office | 2022 | 56 | 59 | $1,593 | $467.66 | 29.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $650.00 | $350.77 | 54.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 42 | 547 | $2,735 | $45.87 | 1.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 256 | $44,800 | $18,963 | 42.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 159 | $15,900 | $8,660 | 54.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 29 | 30 | $9,240 | $3,878 | 42.0% |
| 98966 | Telephone assessment and management service, 5-10 minutes of medical discussion | Office | 2021 | 198 | 298 | $8,046 | $2,497 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $3,519 | $1,834 | 52.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 19 | 19 | $1,330 | $1,262 | 94.9% |
About Amy Webster, APRN
Amy Webster, APRN is a Family healthcare provider based in Russellville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1932544582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Webster, APRN has received a total of $3,082 in payments from pharmaceutical and medical device companies, with $826.19 received in 2024. These payments were reported across 197 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,082).
As a Medicare-enrolled provider, Webster has provided services to 2,799 Medicare beneficiaries, totaling 5,780 services with total Medicare billing of $162,154. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Russellville, KY
- Active Since 05/08/2013
- Last Updated 02/28/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1932544582
Products in Payments
- XIFAXAN (Drug) $247.85
- Kerendia (Drug) $239.46
- ACCRUFER (Drug) $196.14
- VRAYLAR (Drug) $151.53
- TRELEGY ELLIPTA (Drug) $149.98
- Ozempic (Drug) $125.13
- DALVANCE (Drug) $121.27
- EVENITY (Biological) $118.93
- Aimovig (Biological) $106.97
- QULIPTA (Drug) $98.51
- XARELTO (Drug) $96.63
- Rybelsus (Drug) $88.19
- EMGALITY (Drug) $85.21
- MOUNJARO (Drug) $84.74
- NURTEC ODT (Drug) $84.53
- UBRELVY (Drug) $84.33
- ELIQUIS (Drug) $79.22
- Otezla (Drug) $76.75
- TRULICITY (Drug) $75.24
- Saxenda (Drug) $51.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Russellville
Mrs. Melanie Malone, Crnp, CRNP
Family — Payments: $8,263
John Rice, Aprn, APRN
Family — Payments: $5,426
Jena Hamm, Crnp, CRNP
Family — Payments: $2,789
Erinn Basista, Dnp, Aprn, Fnp-C, DNP, APRN, FNP-C
Family — Payments: $2,566
Jessica Mcneese, Apn, APN
Family — Payments: $2,465
Breckenn Findley, Apn, APN
Family — Payments: $2,316